Kadimastem Ltd (KDST) - Cash Flow Conversion Efficiency

Latest as of June 2023: -21.633x

Based on the latest financial reports, Kadimastem Ltd (KDST) has a cash flow conversion efficiency ratio of -21.633x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-3.66 Million ≈ $-9.80K USD) by net assets (ILA169.00K ≈ $453.08 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Kadimastem Ltd to measure how much of total assets are equity-financed.

Kadimastem Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Kadimastem Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore KDST debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Kadimastem Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kadimastem Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
NETCLASS TECHNOLOGY INC Class A Ordinary Shares NASDAQ:NTCL	-0.957x
Triniti Dinamik PT Tbk JK:TRUE	0.022x
Maternus-Kliniken Aktiengesellschaft F:MAK	0.026x
Besra Gold Inc AU:BEZ	0.034x
Shanyuan Co Ltd TWO:4416	-0.097x
Eden Innovations Ltd AU:EDE	0.987x
Latrobe Magnesium Ltd AU:LMG	0.060x
NextTrip Inc NASDAQ:NTRP	-0.316x

Annual Cash Flow Conversion Efficiency for Kadimastem Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Kadimastem Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see KDST market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA-29.15 Million ≈ $-78.14K	ILA-2.75 Million ≈ $-7.39K	0.095x	-96.28%
2023-12-31	ILA-4.36 Million ≈ $-11.69K	ILA-11.09 Million ≈ $-29.72K	2.543x	+104.15%
2022-12-31	ILA326.00K ≈ $873.99	ILA-20.00 Million ≈ $-53.61K	-61.337x	-4278.97%
2021-12-31	ILA15.38 Million ≈ $41.24K	ILA-21.55 Million ≈ $-57.76K	-1.401x	-151.79%
2020-12-31	ILA-8.06 Million ≈ $-21.61K	ILA-21.80 Million ≈ $-58.45K	2.704x	+53.93%
2019-12-31	ILA-12.03 Million ≈ $-32.24K	ILA-21.13 Million ≈ $-56.64K	1.757x	+156.84%
2018-12-31	ILA6.74 Million ≈ $18.06K	ILA-20.83 Million ≈ $-55.84K	-3.091x	+33.28%
2017-12-31	ILA4.28 Million ≈ $11.47K	ILA-19.83 Million ≈ $-53.16K	-4.633x	-390.73%
2016-12-31	ILA-8.56 Million ≈ $-22.94K	ILA-13.63 Million ≈ $-36.55K	1.594x	-85.47%
2015-12-31	ILA-1.02 Million ≈ $-2.74K	ILA-11.22 Million ≈ $-30.08K	10.967x	+273.45%
2014-12-31	ILA1.55 Million ≈ $4.15K	ILA-9.78 Million ≈ $-26.22K	-6.323x	-241.15%
2013-12-31	ILA7.28 Million ≈ $19.50K	ILA-13.48 Million ≈ $-36.15K	-1.853x	--

About Kadimastem Ltd

TA:KDST Israel Biotechnology

Market Cap

$22.18 Million

ILA8.27 Billion ILA

Market Cap Rank

#24697 Global

#356 in Israel

Share Price

ILA2794.00

Change (1 day)

-1.13%

52-Week Range

ILA2548.00 - ILA3680.00

All Time High

ILA78228.15